Lyell Immunopharma reported cash from operations of -$33.92M and free cash flow of -$34.08M for the quarter ended Jun 2026, up 1.6% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | -48.89M | -50.26M | -73.55M | -39.01M | -64.19M | 0.64M | -58.06M | -60.64M | -52.43M | -52.42M | -48.76M | -45.16M | -44.54M | -196.23M | -53.51M | -43.86M | -33.99M | -124.97M | -42.07M | -45.15M | |||||
| Share-based Compensation | 122.50M | 21.18M | 22.03M | 22.41M | 19.12M | 18.36M | 13.88M | 14.22M | 10.52M | 8.46M | 9.15M | 8.28M | 7.62M | 8.08M | 6.02M | 5.00M | 5.23M | 25.57M | 4.29M | 4.53M | |||||
| Gains from Investment Securities | 0.04M | 36.40M | -0.03M | 5.00M | 10.00M | 2.92M | 13.00M | ||||||||||||||||||
| Asset Writedowns and Impairment | 36.40M | 5.00M | -5.00M | 51.30M | 1.44M | ||||||||||||||||||||
| Cash from Operations | -25.49M | -33.21M | -47.85M | -44.33M | -37.10M | -40.27M | -46.21M | -39.16M | -37.69M | -40.63M | -42.02M | -38.09M | -35.04M | -47.24M | -54.74M | -34.46M | -28.58M | -32.25M | -38.51M | -33.92M | |||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.55M | -0.47M | -0.47M | -0.23M | 0.43M | 1.21M | 1.85M | 2.08M | 2.29M | 3.38M | 4.37M | 3.76M | 3.59M | 2.96M | 1.73M | 1.17M | 1.01M | 1.06M | 0.89M | 0.82M | |||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 4.09M | 4.57M | 4.19M | 4.17M | 4.62M | 5.04M | 5.03M | 5.06M | 5.10M | 5.06M | 5.02M | 4.90M | 4.68M | 5.03M | 3.44M | 3.13M | 2.57M | 2.40M | 2.33M | 2.22M | |||||
| Change in Working Capital | |||||||||||||||||||||||||
| Change in Account Payables | -0.99M | 0.10M | 2.94M | -1.77M | 0.02M | -0.53M | 2.07M | 0.38M | -1.41M | 0.42M | -0.11M | -0.52M | -0.57M | -2.04M | -1.65M | -0.23M | -0.78M | 0.33M | 2.38M | -1.46M | |||||
| Change in Accured Expenses | 1.94M | 4.22M | -6.39M | -0.77M | 1.32M | 5.37M | -5.86M | 2.27M | 4.61M | -1.74M | -3.61M | 0.52M | 3.09M | -1.25M | -9.79M | -3.33M | 0.57M | 4.90M | -3.57M | 4.61M | |||||
| Other Working Capital Changes | 5.18M | 2.73M | 2.13M | 1.20M | 1.52M | 0.41M | -1.05M | 0.30M | -2.79M | -0.59M | 0.84M | 1.61M | -3.64M | -2.00M | -2.80M | -0.42M | 2.39M | -0.09M | -3.23M | ||||||
| Investing Activities | |||||||||||||||||||||||||
| Capital Expenditures | 11.60M | 10.27M | 9.73M | 7.17M | 2.79M | 4.58M | 1.53M | 0.93M | 0.20M | 0.03M | 0.22M | 0.14M | 0.06M | 0.04M | 0.25M | 0.17M | 0.06M | 0.30M | 0.19M | 0.15M | |||||
| Sales of Property, Plant and Equipment | 0.26M | 0.02M | |||||||||||||||||||||||
| Change in Acquisitions & Divestments | 142.04M | 70.33M | 79.81M | 121.85M | 106.50M | 110.90M | 142.25M | 187.10M | 178.15M | 156.12M | 130.03M | 161.80M | 133.41M | 123.70M | 154.12M | 93.52M | 74.14M | 52.91M | 54.65M | 69.39M | |||||
| Cash from Investing Activities | -144.91M | -73.86M | -26.12M | 25.02M | -57.09M | 46.65M | 32.15M | 152.91M | 99.67M | -100.69M | 21.99M | 45.01M | 1.92M | 53.51M | 69.47M | 12.65M | 3.35M | -31.36M | 17.38M | 15.62M | |||||
| Financing Activities | |||||||||||||||||||||||||
| Other financing activities | -1.06M | 2.56M | 1.57M | 5.13M | 0.33M | 1.16M | 0.73M | 0.10M | 0.71M | 0.44M | 0.18M | 0.18M | 0.03M | 0.50M | |||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 50.00M | 50.00M | |||||||||||||||||||||||
| Misc. | |||||||||||||||||||||||||
| Cash from Financing Activities | -0.53M | 7.40M | 2.56M | 2.46M | 4.76M | 0.86M | -0.07M | 1.20M | -0.14M | 0.76M | 0.03M | 0.86M | 0.44M | 0.00M | 0.18M | 50.00M | 0.22M | 51.72M | 0.52M | ||||||
| Change in Cash | -170.94M | -99.68M | -71.42M | -16.86M | -89.43M | 7.24M | -14.13M | 114.95M | 61.84M | -140.57M | -20.00M | 7.78M | -33.12M | 6.70M | 14.73M | -21.63M | 24.77M | -63.39M | 30.59M | -17.78M | |||||
| Free Cash Flow | -37.09M | -43.48M | -57.59M | -51.50M | -39.89M | -44.85M | -47.74M | -40.09M | -37.88M | -40.66M | -42.24M | -38.23M | -35.10M | -47.29M | -54.98M | -34.63M | -28.64M | -32.55M | -38.70M | -34.08M | |||||
| Net Cash Flow | -170.94M | -99.68M | -71.42M | -16.86M | -89.43M | 7.24M | -14.13M | 114.95M | 61.84M | -140.57M | -20.00M | 7.78M | -33.12M | 6.70M | 14.73M | -21.63M | 24.77M | -63.39M | 30.59M | -17.78M |